In the past week, DHC stock has gone down by -0.99%, with a monthly gain of 33.19% and a quarterly surge of 21.37%. The volatility ratio for the week is 3.69%, and the volatility levels for the last 30 days are 6.52% for Diversified Healthcare Trust The simple moving average for the past 20 days is 8.72% for DHC’s stock, with a 6.76% simple moving average for the past 200 days.
Is It Worth Investing in Diversified Healthcare Trust (NASDAQ: DHC) Right Now?
The 36-month beta value for DHC is at 2.43. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for DHC is 216.58M, and currently, shorts hold a 2.74% of that float. The average trading volume for DHC on May 23, 2025 was 875.58K shares.
DHC) stock’s latest price update
The stock price of Diversified Healthcare Trust (NASDAQ: DHC) has plunged by -4.14 when compared to previous closing price of 3.14, but the company has seen a -0.99% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-05-20 that NEWTON, Mass.–(BUSINESS WIRE)–Diversified Healthcare Trust (Nasdaq: DHC) today announced that President and Chief Executive Officer Chris Bilotto and Chief Financial Officer and Treasurer Matthew Brown will be presenting at Nareit’s REITweek 2025 Investor Conference in New York, NY on Tuesday, June 3, 2025 at 1:45 p.m. Eastern Time. A live audio webcast of the presentation will be available in a listen-only mode on the company’s website at https://www.dhcreit.com/investors/events-and-presenta.
Analysts’ Opinion of DHC
Many brokerage firms have already submitted their reports for DHC stocks, with B. Riley Securities repeating the rating for DHC by listing it as a “Buy.” The predicted price for DHC in the upcoming period, according to B. Riley Securities is $4.50 based on the research report published on April 03, 2025 of the current year 2025.
Wells Fargo, on the other hand, stated in their research note that they expect to see DHC reach a price target of $4. The rating they have provided for DHC stocks is “Underweight” according to the report published on December 10th, 2020.
DHC Trading at 19.05% from the 50-Day Moving Average
After a stumble in the market that brought DHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.01% of loss for the given period.
Volatility was left at 6.52%, however, over the last 30 days, the volatility rate increased by 3.69%, as shares surge +32.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.58% upper at present.
During the last 5 trading sessions, DHC fell by -0.99%, which changed the moving average for the period of 200-days by -3.06% in comparison to the 20-day moving average, which settled at $2.77. In addition, Diversified Healthcare Trust saw 30.87% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DHC starting from Brown Matthew C., who purchase 2,000 shares at the price of $2.55 back on Nov 13 ’24. After this action, Brown Matthew C. now owns 86,282 shares of Diversified Healthcare Trust, valued at $5,098 using the latest closing price.
Stock Fundamentals for DHC
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.34 for the gross margin
The net margin for Diversified Healthcare Trust stands at -0.19. The total capital return value is set at 0.01. Equity return is now at value -13.96, with -5.66 for asset returns.
Currently, EBITDA for the company is 229.86 million with net debt to EBITDA at -1.91. When we switch over and look at the enterprise to sales, we see a ratio of 0.28.
Conclusion
In conclusion, Diversified Healthcare Trust (DHC) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
